Soravis Osataphan

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control”.

Bromodomain Inhibition Reveals FGF15/19 As a Target of Epigenetic Regulation and Metabolic Control

Diabetes(2022)10.2337/db21-0574

N/A

0.548DataRank · unranked

10 citations

Vissarion Efthymiou, Vicência Sales, Liyuan Zhou, Soravis Osataphan, Yixing Yuchi +18 more

Extended thromboprophylaxis for medically ill patients with cancer: a systemic review and meta-analysis

Blood Advances(2021)10.1182/bloodadvances.2020004118

N/A

0DataRank · unranked

18 citations

Rushad Patell, Thita Chiasakul, Alok A. Khorana, Jeffrey I. Zwicker, Soravis Osataphan

Anti–Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia

New England Journal of Medicine(2023)10.1056/nejmc2307576

N/A

0DataRank · unranked

9 citations

Maria Vamvini, Evan D. Rosen, Lei Pei, Natanie Erlikh, Gurcharan Singh +6 more

Adverse clinical outcomes associated with sickle cell trait at high altitude

Haematologica(2024)10.3324/haematol.2024.285832

N/A

0DataRank · unranked

1 citations

Soravis Osataphan, Rushad Patell, Nigel S. Key, Katherine A. Stafford

Adverse clinical outcomes associated with sickle cell trait at high altitude.

UNC Libraries(2024)10.17615/amzf-4s38

N/A

0DataRank · unranked

0 citations

Nigel S. Key, Soravis Osataphan, Katherine A. Stafford, Rushad Patell